您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (7): 56-59.doi: 10.6040/j.issn.1671-7554.0.2015.518

• • 上一篇    下一篇

认知催眠疗法减轻胃癌化疗患者癌因性疲乏的疗效观察

董秀红   

  1. 潍坊医学院附属医院消化科, 山东 潍坊 261031
  • 收稿日期:2015-05-26 出版日期:2016-07-10 发布日期:2016-07-10
  • 通讯作者: 董秀红. E-mail:dongxhong@126.com E-mail:dongxhong@126.com

Effect of cognitive-behavioral therapy plus hypnosis in controlling cancer-related fatigue in gastric cancer patients receiving chemotherapy

DONG Xiuhong   

  1. Department of Gastroenterology, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong, China
  • Received:2015-05-26 Online:2016-07-10 Published:2016-07-10

摘要: 目的 探讨认知催眠疗法在减轻胃癌患者化疗所致癌因性疲乏中的应用效果。 方法 将60例符合标准的胃癌化疗患者随机分为观察组和对照组,每组30例。2组患者均施行FOLFOX4方案化疗。于化疗第1天开始观察组给予认知催眠疗法,对照组给予常规健康教育,1次/d,每个化疗周期2次。于每周期化疗前、化疗结束后第5天和全部化疗结束后2个月分别评价2组患者的FACIT-F得分及TNF-α、IL-1β、IL-6水平。 结果 化疗前2组患者疲乏程度相当,FACIT-F评分无统计学差异(P>0.05)。化疗后2组FACIT-F评分呈下降趋势,对照组下降更明显,差异有统计学意义(P<0.01);2组TNF-α、IL-1β、IL-6水平呈增加趋势,对照组增加更明显,差异有统计学意义(P<0.01)。化疗结束后2个月观察组FACIT-F评分及TNF-α、IL-1β、IL-6水平仍高于对照组,差异具有统计学意义(P<0.05)。 结论 认知催眠疗法能够降低TNF-α、IL-1β、IL-6水平,明显改善胃癌化疗患者癌性疲劳,有望成为化疗所致癌因性疲乏的一种新的辅助治疗手段。

关键词: 认知催眠疗法, 化疗, 胃癌, 癌因性疲乏

Abstract: Objective To explore the effect of cognitive-behavioral therapy plus hypnosis to reduce cancer-related fatigue(CRF)in gastric cancer patients undergoing chemotherapy. Methods A total of 60 gastric cancer patients undergoing chemotherapy were randomly assigned to 2 groups: observation group(n=30)and control group(n=30). All patients adopted FOLFOX4 chemotherapy scheme. On day 1 of the treatment, the observation group underwent cognitive-behavioral therapy plus hypnosis, while the control group was provided with routine health education. The intervention was performed once a day, twice in each chemotherapy cycle. The score of FACIT-F, levels of TNF-α, IL-1β and IL-6 were measured at baseline, 5 days and 2 months after chemotherapy. Results There were no differences between the 2 groups in fatigue and FACIT-F score before chemotherapy(P>0.05). After chemotherapy, the FACIT-F scores of both groups decreased, and the control group had larger margin of decrease(P<0.01); the levels of TNF-α, IL-1β and IL-6 in both groups increased, and the control group had a larger margin of increase(P<0.05). Two months after chemotherapy, the observation group had higher FACIT-F score and higher levels of TNF-α, IL-1β and IL-6 than the control group(P<0.01). Conclusion Cognitive-behavioral therapy plus hypnosis is able to reduce TNF-α, IL-1β and IL-6 levels, and control fatigue in patients undergoing chemotherapy for gastric cancer. Therefore, it may serve as a promising auxiliary treatment for chemotherapy.

Key words: Chemotherapy, Gastric cancer, Cancer-related fatigue, Cognitive-behavioral therapy plus hypnosis

中图分类号: 

  • R473.5
[1] Neefjes EC, van der Vorst MJ, Blauwhoff-Buskermolen S, et al. Aiming for a better understanding and management of cancer-related fatigue[J]. Oncologist, 2013, 18(10):1135-1143.
[2] Elkins G, Johnson A, Fisher W. Cognitive hypnotherapy for pain management [J]. Am J Clin Hypn, 2012, 54(4):294-310.
[3] Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy(FACT)measurement system[J]. J Pain Symptom Manage,1997, 13(2):63-74.
[4] Cella D, Eton DT, Lai JS, et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy(FACT)Anemia and Fatigue scales[J]. J Pain Symptom Manage, 2002, 24(6):547-561.
[5] 张淼, 王维利, 赵江. 消化系统肿瘤患者癌因性疲乏症状体验的质性研究[J]. 护理学报, 2011, 18(4A):13-16.
[6] Kassam Z, Mackay H, Buckley CA, et al. Evaluating the impact on quality of life of chemoradiation in gastric cancer [J]. Curr Oncol, 2010, 17(4):77-84.
[7] 王海明, 李柏. 癌因性疲乏的诊断及治疗新进展[J]. 中国肿瘤临床与康复, 2014, 21(10):1274-1276.
[8] Kurzrock R. The role of cytokines in cancer-related fatigue [J]. Cancer, 2001, 92(6S):1684-1688.
[9] Collado-Hidalgo A, Bower JE, Ganz PA et al. Cytokine gene polymorphisms and fatigue in breast cancer survivors:early findings [J].Brain Behav Immun, 2008, 22(8):1197-1200.
[10] Lynn SJ, Green JP. The sociocognitive and dissociation theories of hypnosis:Toward a rapprochement [J]. Int J Clin Exp Hypn, 2011, 59(3):277-293.
[11] Elkins G, Johnson A, Fisher W. Cognitive hypnotherapy for pain management [J]. Am J Clin Hypn, 2012, 54(4):294-310.
[12] Van Belle S, Paridaens R, Evers G,et al. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool [J]. Support Care Cancer, 2005, 13(4):246-254.
[13] Hugh Dunstan R, Sparkes DL, Macdonald MM, et al. Altered amino acid homeostasis and the development of fatigue by breast cancer radiotherapy patients:a pilot study [J]. Clinical Biochemistry, 2011, 44(2-3):208-215.
[14] Mills PJ, Parker B, Dimsdale JE, et al. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer[J]. Biol Psychol, 2005, 69(1):85-96.
[15] Alexander S, Minton O, Andrews P, et al. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome [J]. Eur J Cancer, 2009, 45(3):384-392.
[1] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47-52.
[2] 殷雷,殷睿,李文佳,刘帅,吕家驹. CYLD抑制自噬提高膀胱癌细胞吉西他滨化疗敏感性[J]. 山东大学学报(医学版), 2017, 55(8): 1-6.
[3] 宗帅,肖东杰,刘华,郏雁飞,马晓丽,李焕杰,黎娉,郑燕,汪运山. CSN5在胃癌中的表达及与患者预后的相关性[J]. 山东大学学报(医学版), 2017, 55(7): 12-16.
[4] 郝姝桦,郏雁飞,郑燕,马晓丽,孔毅,黎娉,宗帅,张垚,汪运山. ARNT2在胃癌中的表达及临床意义[J]. 山东大学学报(医学版), 2016, 54(7): 6-10.
[5] 徐志宏,刘荣凤,王晓翔,冯莉,姚铁柱,刘红. 养正消积胶囊联合化疗治疗转移性乳腺癌的临床疗效及安全性[J]. 山东大学学报(医学版), 2016, 54(5): 79-83.
[6] 张守彩,高玉,郑桂喜,杨咏梅,刘延红,高杨,王传新. 两种方法评估胃蛋白酶原在萎缩性胃炎和胃癌中的诊断价值[J]. 山东大学学报(医学版), 2016, 54(12): 46-52.
[7] 李帅,李迪诺,袁超凡,梁旭,王玉彬. miR-98-5p靶向调控AKT2基因对人胃癌MGC803细胞增殖的影响[J]. 山东大学学报(医学版), 2016, 54(11): 27-31.
[8] 刘永亮,王秀问. 老年直肠癌术后辅助化疗相关病理特征及预后多因素分析[J]. 山东大学学报(医学版), 2016, 54(1): 48-51.
[9] 韦丽兰, 莫书荣. 红景天苷对人胃癌细胞SGC-7901抑瘤作用的体外实验研究[J]. 山东大学学报(医学版), 2015, 53(12): 12-15,32.
[10] 唐萍, 彭丽婧, 王林娟. 化疗药物外渗1例护理报告[J]. 山东大学学报(医学版), 2014, 52(Z2): 160-160.
[11] 王小林, 王虎, 何发清, 郭兵文. 肝细胞癌经导管肝动脉化疗栓塞术治疗后 CT检查与评价[J]. 山东大学学报(医学版), 2014, 52(S2): 74-75.
[12] 闫文明, 王宏伟. 鼻咽癌同步放化疗的远期疗效分析[J]. 山东大学学报(医学版), 2014, 52(S2): 91-91.
[13] 朱丽华, 赵琳琳, 李盖. 靶向沉默IL-6R基因对胃癌细胞增殖的影响[J]. 山东大学学报(医学版), 2014, 52(S1): 22-23.
[14] 高书明, 李民, 陈汉文, 程才, 王光亚, 苏娜. 脊柱结核患者术后复发与术前化疗时间关系探讨[J]. 山东大学学报(医学版), 2014, 52(S1): 35-35.
[15] 李高峰. 介入治疗联合三维适形放疗治疗原发性巨块型肝癌的疗效观察[J]. 山东大学学报(医学版), 2014, 52(S1): 47-47.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!